“GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE”, ijms, vol. 6, no. 4, pp. 849–855, Apr. 2026, doi: 10.55640/.